Connor Clark & Lunn Investment Management Ltd. Has $1.33 Million Position in Ultralife Co. (NASDAQ:ULBI)

Connor Clark & Lunn Investment Management Ltd. grew its stake in Ultralife Co. (NASDAQ:ULBI) by 13.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 178,170 shares of the technology company’s stock after acquiring an additional 20,840 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Ultralife were worth $1,327,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of ULBI. Barclays PLC increased its stake in Ultralife by 21.3% in the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock valued at $121,000 after purchasing an additional 2,355 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Ultralife by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 232,681 shares of the technology company’s stock valued at $2,104,000 after buying an additional 2,835 shares during the period. Janney Montgomery Scott LLC increased its position in shares of Ultralife by 0.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 447,000 shares of the technology company’s stock valued at $3,330,000 after buying an additional 3,850 shares in the last quarter. IFP Advisors Inc acquired a new stake in Ultralife during the 4th quarter worth $85,000. Finally, Bank of New York Mellon Corp lifted its holdings in Ultralife by 35.7% during the fourth quarter. Bank of New York Mellon Corp now owns 43,541 shares of the technology company’s stock worth $324,000 after acquiring an additional 11,448 shares in the last quarter. 30.68% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded Ultralife from a “buy” rating to a “hold” rating in a report on Tuesday.

Ultralife Stock Performance

Shares of ULBI opened at $5.67 on Thursday. The firm has a market cap of $94.28 million, a P/E ratio of 10.31 and a beta of 1.05. Ultralife Co. has a twelve month low of $5.31 and a twelve month high of $13.39. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.62 and a current ratio of 3.30. The firm’s 50 day moving average price is $6.98 and its two-hundred day moving average price is $7.92.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.